Tag: In the News,NSCLC,genomic test,mutation test,proteomic test
-
Expansion into Genomics | Biodesix
“Proteomic-based tests remain for many clinicians a somewhat exotic option. On other hand, doctors are often more familiar and comfortable with genetic tests, and so Biodesix’s GeneStrat, which uses BioRad’s droplet digital PCR to identify clinically actionable mutations in EGFR, KRAS, ALK, and BRAF in free tumor nucleic acid, has to an extent helped the…